Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endocrine Therapy With or Without Bevacizumab in HR+ Advanced Breast Cancer
NCT00601900Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2008
- Primary completion
- Jun 2014
- Countries
- 2
01
Overview
A Phase 3 trial of bevacizumab in breast cancer, sponsored by National Cancer Institute. Started Sep 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00601900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601900.